Genome Medicine Impact Factor 2025

Genome Medicine is a peer-reviewed open access journal published by BioMed Central (part of Springer Nature). Launched in 2009, the journal publishes research at the intersection of genomics and clinical medicine, with a focus on translational genetics and genomics studies that advance understanding, diagnosis, and treatment of human disease. Its scope spans precision medicine, cancer genomics, computational biology, and genomic technologies.

JOURNAL OVERVIEWAbout Genome Medicine

Genome Medicine serves as a platform for research that bridges the gap between genomic science and clinical application. The journal publishes original research, reviews, method papers, and commentaries on topics including genomic medicine implementation, pharmacogenomics, disease genomics, CRISPR applications, bioinformatics tools, and ethical frameworks for genomic data use. Its editorial board comprises leading researchers in genetics, bioinformatics, and clinical medicine from institutions worldwide.

IMPACT METRICSGenome Medicine Impact Factor 2025

PUBLISHINGPublication Details

SUBMISSIONSubmission and Review Process

Genome Medicine uses a single-blind peer review process in which reviewers know the identity of authors but authors do not know reviewer identities. All manuscripts are screened by the editorial team for scope, novelty, and methodological soundness before being sent for external peer review. At least two independent reviewers evaluate each manuscript.

Initial decision time: Approximately 45 days after submission
Review type: Single-blind peer review
Acceptance rate: Approximately 48%

FEESPublication Fee

Genome Medicine is a fully open access journal. Authors pay an article processing charge (APC) upon acceptance. The APC varies by article type and author affiliation. APC waivers and discounts are available for corresponding authors based in countries eligible for Research4Life programs.

SCOPEScope and Coverage

Genome Medicine publishes research at the interface of genomics and medicine. Major topic areas include: precision medicine and pharmacogenomics; cancer genomics and liquid biopsy; rare disease genetics; CRISPR and genome editing; microbial genomics and infectious disease; genomic data science and AI in medicine; implementation of genomic medicine in clinical practice; and ethical, legal, and social implications of genomics.

INDEXINGIndexing and Abstracting

Genome Medicine is indexed in Scopus, Science Citation Index Expanded (Web of Science), SCImago Journal Rank, UGC-CARE, PubMed, PubMed Central, Google Scholar, and DOAJ. These indexations ensure wide visibility and lasting scholarly impact of published articles.

CITATIONCitation Style

Genome Medicine uses a numbered citation system (Vancouver style). References are numbered consecutively in the order they appear in the text. Authors are encouraged to use reference management software such as EndNote or Zotero.

ABBREVIATIONJournal Abbreviation

The standard ISO 4 abbreviation for Genome Medicine is Genome Med.

EDITORIALEditorial Process and Standards

Genome Medicine follows editorial standards set by the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE). The editorial team evaluates submissions based on scientific rigor, novelty, relevance to genomic medicine, and potential clinical or translational impact. All research articles undergo comprehensive peer review before acceptance.

FAQsFrequently Asked Questions